Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses (Q73437152)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Robert Korngold

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Joseph C Marini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Monica E de Baca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

George F Murphy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Jill Giles-Komar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

Biology of Blood and Marrow Transplantation

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

292-303

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

Allogeneic hematopoietic cell transplantation for multiple myeloma

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Bone marrow transplantation for nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

ICAM-1 expression on epidermal keratinocytes in cutaneous graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Tumor necrosis factor regulation of major histocompatibility complex gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

The role of cytokines and adhesion molecules in the development of inflammatory injury

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

TNF-alpha antagonists for the treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Role of mast cells in early epithelial target cell injury in experimental acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

T-cell subsets mediate graft-versus-myeloid leukemia responses via different cytotoxic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Gamma-IFN induces a differential expression of HLA-DR, DQ and DP antigens on peripheral blood myeloid leukemic blasts at various stages of differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

The graft-versus-leukemia effects of allogeneic cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Adoptive allogeneic immunotherapy--history and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Cytokine dysregulation as a mechanism of graft versus host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

The graft-versus-leukemia effect of post-transplant donor leukocyte infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900087-9

7 January 2021

10.1016/S1083-8791(03)00087-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12766879%20AND%20SRC:MED&resulttype=core&format=json